European Union

Apparatus for identifying left/right eyes

The European Patent Office has published patent application EP2024164800A1 concerning an apparatus for identifying left and right eyes. The application was published on March 18, 2026, and includes designated states across Europe. The inventors have not yet filed their designation.

Novel Biaryl Ring Compound as Immunomodulator Patent Application

The European Patent Office has published a patent application (EP2024125662A1) by Shanghai Longwood Biopharmaceuticals Co., Ltd. for a novel biaryl ring compound described as an immunomodulator. The application details the preparation and application of this compound, with designated states including most European countries.

EPO Patent: Tetrahydrocyclopentyl Pyrrole Derivative Preparation and Use

The European Patent Office has published patent application EP4635949A1 concerning the preparation and use of a substituted tetrahydrocyclopentyl pyrrole derivative. The patent application lists Jiangsu NHWA Pharmaceutical Co., Ltd as the applicant and details various inventors.

EPO Patent Granted for Proximod Crystal Form

The European Patent Office has granted a patent (EP4635945A1) for a crystal form of Proximod, its preparation method, and its use. The patent was published on March 18, 2026, with applicants Jiankuan (Suzhou) Biotechnology Co., Ltd and the Institute of Materia Medica, Chinese Academy of Medical Sciences.

EPO Patent Filing for Sickle Cell Disease Treatment

The European Patent Office has published a patent application filed by BioLineRx Ltd. and The Washington University for a treatment of sickle cell disease. The patent, designated EP4630032A1, was published on March 18, 2026.

EPO Patent for Bispecific Fusion Protein Targeting TNF-α and IL-17A

The European Patent Office has published patent application EP4635988A1 for a bispecific fusion protein targeting TNF-α and IL-17A, filed by Jiangsu Kanion Pharmaceutical Co., Ltd. The patent is related to therapeutic uses for conditions such as inflammation and autoimmune diseases.

EPO Patent Publication: Novel Composition for Hair and Scalp Condition

The European Patent Office has published a new patent application, EP4511051A1, detailing a novel composition for improving hair and scalp condition. The publication includes details on the applicants, inventors, and International Patent Classifications related to the composition.

EPO Patent EP4518972A2 on Vectorized Anti-Complement Antibodies

The European Patent Office has published patent application EP4518972A2 filed by RegenxBio Inc. The patent covers vectorized anti-complement antibodies and related administration methods. The publication date is March 18, 2026.

Patent EP4525868A1: Deuterated Domperidone for Gastroparesis

The European Patent Office has published patent application EP4525868A1, filed by CinDome Pharma, Inc., for deuterated domperidone intended for treating gastroparesis. The publication date is March 18, 2026.

Myostatin Inhibitor for Spinal Muscular Atrophy Treatment Patent

The European Patent Office has published a patent application (EP4518970A2) for Scholar Rock, Inc. concerning the use of a myostatin inhibitor for treating spinal muscular atrophy. The patent details specific chemical compounds and their therapeutic applications.